Article info

Download PDFPDF
Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model

Authors

  1. Address correspondence and reprint requests to Margit M. Janát-Amsbury, MD, PhD, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Utah, 30 N 1900 E, SOM, 2A242 Salt Lake City, UT, 84132-0001. E-mail: margit.janat-amsbury{at}hsc.utah.edu.

Citation

Taurin S, Yang C, Reyes M, et al
Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model

Publication history

  • Received June 16, 2017
  • Accepted August 8, 2017
  • First published January 1, 2018.
Online issue publication 
January 01, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.